Home/Field notes/No. 1 · Pharma and regulated manufacturing

What a warning letter actually starts

A citation reads like an ending. Inside the company it is the first page of an eighteen-month project nobody has the hours to run.

What happens after an FDA warning letter?

An FDA warning letter names what FDA believes are significant violations and asks for a response within a set timeframe. The response can include a plan to fix things, and FDA checks that plan. A close-out letter comes only once FDA has verified the fixes, usually at a follow-up inspection. Some violations can't be corrected by their nature. Those never get a close-out.

An FDA warning letter leads to a written response, a correction plan and FDA verification, usually by follow-up inspection, then either a close-out letter or escalation.

Source: FDA, “About Warning and Close-Out Letters”

That's the official version. Inside the company, it looks like this.

A warning letter reads like an ending. It is published, it is public, and it names the company. Inside the company it is the opposite. It is the first page of an eighteen-month project that nobody on staff has the hours to run.

The letter itself is rarely the hard part. The hard part is the response deadline, the remediation plan, and the fact that the agency has usually asked for a named consultant, a third party sitting in the lab, or an audit of every system before US supply resumes. A quality team does not absorb that alongside its existing work. It is a second job handed to people who already had one.

Who gets hired after a warning letter

The quality team that got the letter already has a full-time job. So most of the remediation work goes outside, usually to one of these:

  • Remediation consultants, sometimes the specific consultant the agency asked for. They plan the fix and run it.
  • Contract QA firms, who add people to a quality team that can't take on a second workload.
  • Third-party auditors. They sit in the lab, or review every system before US supply starts again.

In our experience the site doesn't run an open search for any of them. It calls two or three people it already knows.

You can see a live FDA warning letter signal on our desk, linked to the letter itself.

Nobody goes looking for help the week the letter lands. They go looking three weeks later, when someone finally counts the hours.

Which is why timing beats the list. Every remediation consultant and every contract QA firm is reading the same public page on the same morning. The ones who win the work are not the ones who found the letter first. They are the ones who reached the site at the moment the internal math stopped working.

And by then the site is not shopping. It is asking two or three people it already knows whether they can take this on. Being one of those two or three is the whole game, and it gets decided long before any letter is published.

Other markets work the same way. In recruitment, the hiring announcement comes last. In brand work, account reviews are decided before the pitch. If you'd rather someone ran this for you, we're a B2B lead generation agency built on qualified introductions.

Harsh Shah routes qualified demand to B2B companies selling into regulated markets.

Next field noteThe hiring announcement is the last signal, not the first
Read →

FDA warning letters: common questions

What is an FDA warning letter?

It's often how FDA tells a company or person that it has found what it believes are significant violations of federal requirements. The letter names the concerns, poor manufacturing practices for example. The recipient gets a chance to respond, and can disagree if it has supporting information.

How long does a company have to respond to an FDA warning letter?

The letter sets the deadline. FDA's own overview only says the letter asks for a response within a certain timeframe. Work from the date in the letter you received.

What's the difference between a warning letter and a Form 483?

A Form 483 is handed to company management at the end of an inspection and lists conditions the investigator thinks may be violations. FDA says it is not a final agency determination. Before deciding on further action, FDA looks at the 483 alongside the inspection report, the evidence and the company's responses. A warning letter is one possible outcome.

This is our reading of public FDA material, not legal or regulatory advice. If you've received a letter, talk to regulatory counsel.

Want the next one to be yours?

Tell us what you sell and who should be buying it. We'll tell you honestly whether we can find them.